Search
Displaying results 591 to 600 of 601.
On the effectiveness of non-pharmaceutical interventions to combat pathogens
The novel coronavirus known as SARS-CoV-2 first appeared in the Chinese city of Wuhan at the end of 2019 and spread rapidly around the world. The first case in Germany was confirmed in January 2020. In early 2020, SARS-CoV-2 was identified as the cause of the infectious…
Mpox/Monkeypox - What the HZI experts say
Monkeypox virus (MPXV) is related to the eradicated smallpox virus. Despite the name, monkeys are not the natural reservoir of the virus. Instead, rodents are probably the reservoir from which monkeys can also contract the virus. It is currently unknown via which…
Paths into the unknown
EM started in 1982 at the former Gesellschaft für Biotechnologische Forschung (GBF) and in 1989 moved into a new building, which presented a major challenge in itself: The floors of the new building were covered with vibrating screed, which is not suitable for…
Hair follicle models from the 3D printer
Hair follicles are complex structures that surround the hair root, anchoring it to the skin and giving the hair its hold. At the same time, the area between the skin and the follicle provides optimal conditions for microorganisms to multiply unhindered. This often leads…
Making sense of the data jungle
Antibiotic resistance is rising worldwide and poses a major challenge to healthcare systems. Understanding the underlying processes of how and why some bacteria develop such defenses is critical. Differences in bacterial gene expression—in which the information in a…
Leendertz: "Human health cannot be viewed in isolation"
Contact between humans and animals is becoming increasingly closer. This is due to the growing world population, the ever deeper intrusion of humans into natural habitats, the hunting of wildlife, and intensive livestock farming and agriculture. Combined with…
New vector vaccine against COVID-19 provides long-term protection
In 2022, researchers from the department “Viral Immunology” headed by Prof. Luka Cicin-Sain at the Helmholtz Centre for Infection Research reported on the novel vector vaccine for the first time. The promising immunogenic profile of the MCMV-based vaccine has now been…
